팔로우
David R. Croucher
David R. Croucher
garvan.org.au의 이메일 확인됨
제목
인용
인용
연도
Temporal regulation of EGF signalling networks by the scaffold protein Shc1
Y Zheng, C Zhang, DR Croucher, MA Soliman, N St-Denis, A Pasculescu, ...
Nature 499 (7457), 166-171, 2013
3262013
CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan
C Vennin, P Mélénec, R Rouet, M Nobis, AS Cazet, KJ Murphy, ...
Nature communications 10 (1), 3637, 2019
2402019
Crosstalk and signaling switches in mitogen-activated protein kinase cascades
D Fey, DR Croucher, W Kolch, BN Kholodenko
Frontiers in physiology 3, 355, 2012
2172012
Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells
F Hochgräfe, L Zhang, SA O'Toole, BC Browne, M Pinese, A Porta Cubas, ...
Cancer research 70 (22), 9391-9401, 2010
2142010
Revisiting the biological roles of PAI2 (SERPINB2) in cancer
DR Croucher, DN Saunders, S Lobov, M Ranson
Nature Reviews Cancer 8 (7), 535-545, 2008
2142008
The extracellular matrix as a key regulator of intracellular signalling networks
JF Hastings, JN Skhinas, D Fey, DR Croucher, TR Cox
British journal of pharmacology 176 (1), 82-92, 2019
2112019
Nedd4 controls animal growth by regulating IGF-1 signaling
XR Cao, NL Lill, N Boase, PP Shi, DR Croucher, H Shan, J Qu, ...
Science signaling 1 (38), ra5-ra5, 2008
2052008
Signaling pathway models as biomarkers: Patient-specific simulations of JNK activity predict the survival of neuroblastoma patients
D Fey, M Halasz, D Dreidax, SP Kennedy, JF Hastings, N Rauch, ...
Science signaling 8 (408), ra130-ra130, 2015
1732015
Tissue‐type plasminogen activator requires a co‐receptor to enhance NMDA receptor function
AL Samson, ST Nevin, D Croucher, B Niego, PB Daniel, TW Weiss, ...
Journal of neurochemistry 107 (4), 1091-1101, 2008
1452008
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis
M Papanicolaou, AL Parker, M Yam, EC Filipe, SZ Wu, JL Chitty, K Wyllie, ...
Nature communications 13 (1), 4587, 2022
1272022
Axl-EGFR receptor tyrosine kinase hetero-interaction provides EGFR with access to pro-invasive signalling in cancer cells
M Vouri, DR Croucher, SP Kennedy, Q An, GJ Pilkington, S Hafizi
Oncogenesis 5 (10), e266-e266, 2016
1202016
Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway
DR Croucher, F Hochgräfe, L Zhang, L Liu, RJ Lyons, D Rickwood, ...
Cancer research 73 (6), 1969-1980, 2013
1022013
Activin A is essential for neurogenesis following neurodegeneration
A Abdipranoto-Cowley, JS Park, D Croucher, J Daniel, S Henshall, ...
Stem cells 27 (6), 1330-1346, 2009
992009
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer
A Cipponi, DL Goode, J Bedo, MJ McCabe, M Pajic, DR Croucher, ...
Science 368 (6495), 1127-1131, 2020
962020
The under-appreciated promiscuity of the epidermal growth factor receptor family
SP Kennedy, JF Hastings, JZR Han, DR Croucher
Frontiers in cell and developmental biology 4, 88, 2016
872016
Signalling by protein phosphatases and drug development: a systems‐centred view
LK Nguyen, D Matallanas, DR Croucher, A Von Kriegsheim, ...
The FEBS journal 280 (2), 751-765, 2013
732013
Intravital FRAP imaging using an E-cadherin-GFP mouse reveals disease-and drug-dependent dynamic regulation of cell-cell junctions in live tissue
Z Erami, D Herrmann, SC Warren, M Nobis, EJ McGhee, MC Lucas, ...
Cell reports 14 (1), 152-167, 2016
722016
Bimolecular complementation affinity purification (BiCAP) reveals dimer-specific protein interactions for ERBB2 dimers
DR Croucher, M Iconomou, JF Hastings, SP Kennedy, JZR Han, ...
Science signaling 9 (436), ra69-ra69, 2016
692016
Intravital imaging to monitor therapeutic response in moving hypoxic regions resistant to PI3K pathway targeting in pancreatic cancer
JRW Conway, SC Warren, D Herrmann, KJ Murphy, AS Cazet, C Vennin, ...
Cell reports 23 (11), 3312-3326, 2018
682018
Kinetic analysis of plasminogen activator inhibitor type-2: urokinase complex formation and subsequent internalisation by carcinoma cell lines
F Al-Ejeh, D Croucher, M Ranson
Experimental cell research 297 (1), 259-271, 2004
682004
현재 시스템이 작동되지 않습니다. 나중에 다시 시도해 주세요.
학술자료 1–20